top of page

Press releases
Reaching new heights

Press releases
Reaching new heights

-
18. Dez. 20204 Min. Lesezeit
Neuron23 Closes $113.5 Million Series A and B Financing led by Westlake Village BioPartners, Klein
December 16, 2020 Biotechnology company launches to accelerate development of precision medicines for genetically defined neurological...
1.318

-
3. Sept. 20194 Min. Lesezeit
Case Study Origenis GmbH: With Small Molecules against Neurodegenerative Diseases
September 03, 2019 Mithilfe ihrer KI-basierten Small Molecules Technologie schafften es Michael Almstetter und seine zwei Mitstreiter...
385

-
4. Juni 20192 Min. Lesezeit
Origenis GmbH Announces Research Collaboration with U.S. Cancer Center
June 04, 2019 Origenis AI Discovery Platform to Identify and Optimize Small Molecule Preclinical Development Candidates for Glioblastoma...
358
bottom of page